[1. GORNIK H.L., GERHARD-HERMAN M., BECKMAN J.A. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol. 2005; 2 3(22):5211-6.10.1200/JCO.2005.00.745]Search in Google Scholar
[2. MAISCH B.I., SEFEROVIĆ P.M., RISTIĆ A.D., et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004 Apr; 25(7):587-610.10.1016/j.ehj.2004.02.002]Search in Google Scholar
[3. REFAAT M.M., KATZ W.E. Neoplastic Pericardial Effusion. Clinical Cardiology 2011; 34(10):593-8.10.1002/clc.20936]Search in Google Scholar
[4. LEWINTER M.M., TISCHLER M.D. Pericardial diseases. In: Bonow R.O., Mann D.L., Zipes D.P., Libby P., eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. Ed 9. Philadelphia, 2011, Saunders, 1651-1670.]Search in Google Scholar
[5. SAGRISTÀ-SAULEDA J., MERCÉ J., PERMANYER-MIRALDA G., SOLER-SOLER J. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000; 109(2):95-101.10.1016/S0002-9343(00)00459-9]Search in Google Scholar
[6. MAGGIOLINI S., OSCULATI G., VITALE G. Utility and safety of diagnostic pericardiocentesis. European Heart Journal 2005; 26(10):1046-7.10.1093/eurheartj/ehi240]Search in Google Scholar
[7. SIDAWY M.K, ALI S.Z. Fine needle aspiration cytology. Elsevier Health Sciences, 2007.]Search in Google Scholar
[8. RIZZARDI C., BARREZI E., BROLLO A., CASSETTI P., SCNEIDER M., MELATO M. Primary pericardial mesothelioma in an asbestos-exposed patient with previous heart surgery. Anticancer Research 2010; 30 (1):1323-6.]Search in Google Scholar
[9. KWON H.Y., CHO K.I., KIM S.M., et al. A rare case with primary undifferentiated carcinoma of pericardium. Journal of Cardiovascular Ultrasound. 2010; 18(3):104-107.10.4250/jcu.2010.18.3.104]Search in Google Scholar
[10. PETCU D.P., PETCU C., POPESCU C.F., BĂTĂIOSU C., ALEXANDRU D. Clinical and cytological correlations in pericardial effusions with cardiac tamponade. Rom J Morphol Embryol. 2009; 50(2):251-6.]Search in Google Scholar
[11. KOSS G.L., MELAMED M.R., Effusions in the absence of cancer and effusions in the presence of cancer. In: Koss G.L., Melamed M.R. (eds), Koss’ diagnostic cytology and its histopathologic bases, 5th edition, Lippincott Williams & Wilkins, Philadelphia, 2006.]Search in Google Scholar
[12. REUTER H., BURGESS L., VAN VUUREN W., DOUBELL A., Diagnosing tuberculous pericarditis. QJM, 2006; 99(12):827-39.10.1093/qjmed/hcl123]Search in Google Scholar
[13. FIOCCO M., KRASNA M.J., The management of malignant pleural and pericardial effusions. Hematol Oncol Clin North Am 1997; 11(2):253-65.10.1016/S0889-8588(05)70429-9]Search in Google Scholar
[14. WANG P.C., YANG K.Y., CHAO J.Y., LIU J.M., PERNG R.P., YEN S.H., Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer. Chest 2000; 118(3):744-749.10.1378/chest.118.3.74410988197]Search in Google Scholar
[15. DRAGOESCU E.A, LIU L. Pericardial fluid cytology: An analysis of 128 specimens over a 6 year period. Cancer Cytopathol. 2013, 121:242-251.10.1002/cncy.2124623362233]Search in Google Scholar
[16. HAE-OK JUNG. Pericardial effusion and pericardiocentesis: Role of echocardiography. Korean Circ J. 2012; 42(11): 725-34.10.4070/kcj.2012.42.11.725351870523236323]Search in Google Scholar
[17. KARATOLIOS K., PANKUWEIT S., MAISCH B. Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion. Heart Fail Rev. 2013; 18(3):337-44. 10.1007/s10741-012-9327-x22638889]Search in Google Scholar